scholarly article | Q13442814 |
P2093 | author name string | Nyindo M | |
Farah IO | |||
Reid GD | |||
Strand M | |||
Soisson LA | |||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | antibody | Q79460 |
Schistosoma mansoni | Q2324689 | ||
P304 | page(s) | 4782-4789 | |
P577 | publication date | 1993-11-01 | |
P1433 | published in | Journal of Immunology | Q3521441 |
P1476 | title | Protective immunity in baboons vaccinated with a recombinant antigen or radiation-attenuated cercariae of Schistosoma mansoni is antibody-dependent | |
P478 | volume | 151 |
Q33615566 | A Schistosoma mansoni fatty acid-binding protein, Sm14, is the potential basis of a dual-purpose anti-helminth vaccine |
Q92867229 | An investigation into the role of chronic Schistosoma mansoni infection on Human Papillomavirus (HPV) vaccine induced protective responses |
Q39521804 | Cellular and humoral immune responses and protection against schistosomes induced by a radiation-attenuated vaccine in chimpanzees |
Q28073949 | Do schistosome vaccine trials in mice have an intrinsic flaw that generates spurious protection data? |
Q37079841 | Experimental vaccines in animal models for schistosomiasis |
Q34004360 | Human immune responses to Schistosoma mansoni vaccine candidate antigens |
Q34001634 | Intranasal administration of synthetic recombinant peptide-based vaccine protects mice from infection by Schistosoma mansoni. |
Q51724837 | Molecular cloning, purification and characterisation of myosin of human lymphatic filarial parasite Brugia malayi. |
Q31016186 | Morbidity and immune response to natural schistosomiasis in baboons ( Papio anubis ) |
Q27008897 | Novel therapeutic and prevention approaches for schistosomiasis: review |
Q37521765 | Parameters of the attenuated schistosome vaccine evaluated in the olive baboon |
Q34721343 | Previous or ongoing schistosome infections do not compromise the efficacy of the attenuated cercaria vaccine |
Q35665650 | Protective Potential of Antioxidant Enzymes as Vaccines for Schistosomiasis in a Non-Human Primate Model. |
Q37216479 | Protective and antifecundity effects of Sm-p80-based DNA vaccine formulation against Schistosoma mansoni in a nonhuman primate model |
Q31920496 | Role of adult worm antigen-specific immunoglobulin E in acquired immunity to Schistosoma mansoni infection in baboons |
Q34071134 | Sm-p80-based DNA vaccine provides baboons with levels of protection against Schistosoma mansoni infection comparable to those achieved by the irradiated cercarial vaccine |
Q46526867 | Structural changes of Schistosoma mansoni adult worms recovered from C57BL/6 mice treated with radiation-attenuated vaccine and/or praziquantel against infection |
Q41414576 | Transmission electron microscopic observations on ultrastructural alterations in Schistosoma mansoni adult worms recovered from C57BL/6 mice treated with radiation-attenuated vaccine and/or praziquantel in addition to passive immunization with norma |
Q30425005 | Vaccines to combat the neglected tropical diseases |
Q26800061 | Why the radiation-attenuated cercarial immunization studies failed to guide the road for an effective schistosomiasis vaccine: A review |
Search more.